SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+9.57%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.65B
AUM Growth
+$1.65B
(+4.6%)
Cap. Flow
+$165M
Cap. Flow
% of AUM
10.04%
Top 10 Holdings %
Top 10 Hldgs %
69.29%
Holding
60
New
5
Increased
18
Reduced
9
Closed
10
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$47M |
| 2 |
Ascendis Pharma
ASND
|
$46.5M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$45.3M |
| 4 |
Sanofi
SNY
|
$33.9M |
| 5 |
Align Technology
ALGN
|
$17.5M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$29.8M |
| 2 |
Intuitive Surgical
ISRG
|
$18.1M |
| 3 |
iRhythm Technologies
IRTC
|
$17.6M |
| 4 |
United Therapeutics
UTHR
|
$16.2M |
| 5 |
Eli Lilly
LLY
|
$14.7M |
Sector Composition
| 1 | Healthcare | 99.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
26
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $13.7M | 0.81% |
638,398
-182,267
| -22% | -$3.9M |
|
27
Alnylam Pharmaceuticals
ALNY
$58.6B
| $13.4M | 0.8% |
+56,448
| New | +$13.4M |
|
28
Travere Therapeutics
TVTX
$1.75B
| $12.2M | 0.72% |
578,268
+183,590
| +47% | +$3.86M |
|
29
Y-mAbs Therapeutics
YMAB
$390M
| $10.7M | 0.64% |
2,194,278
| – | – |
|
30
IDEAYA Biosciences
IDYA
$2.26B
| $8.62M | 0.51% |
474,530
-180,226
| -28% | -$3.27M |
|
|
IMGN
31
DELISTED
Immunogen Inc
IMGN
| $8.36M | 0.5% |
1,686,154
+1,183,761
| +236% | +$5.87M |
|
32
Kura Oncology
KURA
$732M
| $7.37M | 0.44% |
+593,561
| New | +$7.37M |
|
|
AGEN
33
Agenus
AGEN
$136M
| $6.95M | 0.41% |
147,452
+23,263
| +19% | +$1.1M |
|
34
Arcus Biosciences
RCUS
$1.24B
| $6.51M | 0.39% |
314,811
-66,534
| -17% | -$1.38M |
|
35
Fulcrum Therapeutics
FULC
$353M
| $4.6M | 0.27% |
631,411
-165,851
| -21% | -$1.21M |
|
|
GRTX
36
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $4.59M | 0.27% |
3,083,712
| – | – |
|
|
INZY
37
DELISTED
Inozyme Pharma
INZY
| $3.84M | 0.23% |
3,655,308
| – | – |
|
38
NextCure
NXTC
$13.3M
| $3.77M | 0.22% |
222,655
| – | – |
|
|
NCNA
39
NuCana
NCNA
$5.8M
| $3.7M | 0.22% |
1,120
| – | – |
|
40
Bolt Biotherapeutics
BOLT
$9.29M
| $3.58M | 0.21% |
137,722
| – | – |
|
41
Geron
GERN
$893M
| $3.53M | 0.21% |
1,459,589
+270,381
| +23% | +$654K |
|
42
PDS Biotechnology
PDSB
$60.6M
| $1.88M | 0.11% |
142,635
| – | – |
|
|
OBSV
43
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $689K | 0.04% |
4,749,623
| – | – |
|
44
Synlogic
SYBX
$17.4M
| $437K | 0.03% |
38,331
| – | – |
|
|
FUSN
45
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $369K | 0.02% |
117,099
| – | – |
|
|
46
Gilead Sciences
GILD
$140B
| – | – |
-482,400
| Closed | -$29.8M |
|
47
Insmed
INSM
$30.3B
| – | – |
-220,665
| Closed | -$4.75M |
|
|
48
Intuitive Surgical
ISRG
$158B
| – | – |
-96,300
| Closed | -$18.1M |
|
49
iShares Russell 2000 ETF
IWM
$66.6B
| – | – |
0
| – | – |
|
50
Adicet Bio
ACET
$60.8M
| – | – |
-491,965
| Closed | -$7M |
|